Related Experiment Video

Updated: Aug 16, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

Premature atherosclerosis in systemic lupus erythematosus

N T Ilowite1

  • 1Children's Hospital, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA.

The Journal of Rheumatology. Supplement
|April 27, 2000
PubMed

Insights

Systemic lupus erythematosus (SLE) patients face premature atherosclerosis due to inflammation and treatments. Early childhood interventions targeting dyslipoproteinemia are crucial for prevention.

Area of Science:

  • Rheumatology
  • Cardiology
  • Pediatrics

Background:

  • Premature atherosclerosis is a significant complication in Systemic Lupus Erythematosus (SLE).
  • Improving life expectancy in SLE highlights the growing clinical importance of managing atherosclerosis.
  • Atherosclerosis development starts in childhood, necessitating early preventive strategies.

Purpose of the Study:

  • To review the etiologies of premature atherosclerosis in pediatric SLE patients.
  • To discuss management strategies for dyslipoproteinemia (DL) in this population.
  • To explore preventive measures against atherosclerosis in childhood SLE.

Main Methods:

  • Literature review of studies on atherosclerosis in SLE.
  • Analysis of potential contributing factors: dyslipoproteinemia, hypercoagulation, vasculitis, hypertension.
  • Evaluation of therapeutic interventions including diet, fish oil, and lipid-lowering drugs.

Main Results:

  • Dyslipoproteinemia (DL) is a key factor, potentially linked to chronic inflammation, corticosteroid use, antiphospholipid antibodies, and nephrotic syndrome.
  • Anticardiolipin antibodies (aCL) may correlate with DL.
  • Dietary modifications and fish oil may not fully resolve DL, suggesting a role for lipid-lowering drugs.

Conclusions:

  • Early atherosclerosis prevention in childhood SLE is essential.
  • Comprehensive management of DL, potentially including pharmacotherapy, is vital.
  • Addressing multiple risk factors is key to preventing atherosclerosis complications in SLE.

More Related Videos

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...